close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar129Point71
Implied share price

Buy Undervalued by 26.9%

5% margin of safety What's this?

EV / EBITDA
Use Average
AMGN
Amgen, Inc.
SNY
Sanofi SA (ADR)
Change
DNA
Genentech, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
NVO
Novo Nordisk A/S (ADR)
Change
11.1 8.8 6.51 17.08 20.28 2.42
All amounts in millions
from last financial year
         
Implied Share Price $129.71 $98.10 $62.86 $27.06 $686.26
Market Cap 76,632 147,662 100,042 80,660 76,077
Net Debt 2,468 8,094 -3,369 6,361 -15,605
Enterprise Value (EV) 79,100 80,819 96,673 86,971 77,735
Revenue 17,265 35,957 13,418 9,702 78,026
EBITDA 8,985 12,422 5,661 4,288 32,135
Percent 52.0 % 34.5 % 42.2 % 44.2 % 41.2 %
EBIT 7,500 7,825 5,069 4,010 29,562
Percent 43.4 % 21.8 % 37.8 % 41.3 % 37.9 %
Balance Sheet          
Total Assets 54,298 100,407 21,787 21,239 65,669
Total Liabilities 35,238 43,069 6,116 11,930 25,037
Shareholders Equity 19,060 57,338 15,671 9,309 40,632.0

Comments

No comments yet. Login to comment.